Sanderson Farms, a major U.S. poultry producer, said the supply of antibiotic-free (ABF) chicken is significantly greater than demand, an indication that overproduction could eat into processors’ profits, reports Reuters.
In a regulatory filing, the company stated ABF chicken made up about 40% of all fresh U.S. production, but only accounted for 6% of sales for ABF sold products. Sanderson’s assertion challenges a belief that the U.S. supply of ABF chicken is not enough to meet demand.
As recently as three years ago, some poultry producers claimed that switching from conventionally raised birds would be too expensive to stay in business.
Meanwhile, public health experts have warned of a link between antibiotic-using farms and the rise of drug-resistant bacteria, a move that has caused large chicken companies and restaurants , including Tyson Foods and McDonald’s, to cut those products from their supply channels. (Source: Reuters)
Articles are chosen for summary in this Market Intelligence blog based on newsworthiness in conjunction with The Infinite Loop themes. Any opinions and views expressed in the articles are generally those of the underlying author from the source listed, are not necessarily current as of the date of this blog, may change as market or other conditions change, and may differ from views expressed by Ivy Investment Management Company and its associates or affiliates. Actual investments or investment decisions made by Ivy Investment Management Company and its affiliates will not necessarily reflect the views expressed in the articles. These articles are distributed for educational purposes only and are not investment advice or a recommendation to purchase, sell or hold any specific security mentioned in the article or to engage in any investment strategy. Investment decisions should always be made based on each investor’s specific financial needs, objectives, goals, time horizon and risk tolerance. Securities discussed may not be suitable for all investors.